Costello Syndrome
8
6
6
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 85/100
12.5%
1 terminated out of 8 trials
0.0%
-86.6% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Clinical Trials (8)
Clinical Genetics Branch Eligibility Screening Survey
Clinical, Genetic, and Epidemiologic Study of Children and Adults With RASopathies
Pathophysiology Analysis of "Costello Syndrome" on Cellular Models
Acceptance and Commitment Therapy for Caregivers of Children With a RASopathy: An Internal Pilot Feasibility Study and Follow-up Randomized Controlled Trial
RASopathy Biorepository
Prevalence and Characterization of Pain in RASopathies
Solid Tumors in RASopathies
Effect of RAS/MAPK Pathway Hyperactivation on Growth' and Bone' Profile of the RASopathies